Fas (CD95) is a cell surface glycoprotein that mediates apoptotic cell deat
h when cross-linked with agonistic anti-Fas monoclonal antibodies (MAbs) or
the endogenous Fas ligand, In this study, we investigated the in vitro bio
logical properties of a panel of anti-human Fas MAbs, We found that five an
ti-Fas MAbs of IgG(1) subclass (B.E28, B.G30, B.L25, DX2, and B.G34) induce
d marked apoptotic cell death in Fas-expressing leukemia cells, although th
is killing was delayed when compared to the cytolytic effect mediated by th
e prototypic anti-Fas MAb of IgM subclass (clone CH-11). On the other hand,
four clones (ZB4, B.G27, B.D29, and B.K14) efficiently blocked apoptotic c
ell death induced by the CH-11 MAb or Fas ligand, The ability of these MAbs
to inhibit cell death appeared to correlate with their relative affinity f
or the Fas molecule, Furthermore, different clones recognized the same epit
ope and elicited different effects (induction or inhibition of cell killing
); conversely, different clones elicited the same effect but recognized dif
ferent epitopes, These results suggest that the different biological effect
s of anti-Fas MAbs would not be mediated in an epitope-restricted manner. T
he relative binding affinity might correlate to some extent with the biolog
ical properties of the MAb.